Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 220329-19-1
2. Privituss
3. (s)-cloperastine Fendizoate
4. 09837k287s
5. 1-[2-[(s)-(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic Acid
6. Benzoic Acid, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)-, Compd. With (-)-1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1)
7. Benzoic Acid, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)-, Compd. With 1-(2-((s)-(4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1)
8. Piperidine, 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)-, (-)-, 2-((6-hydroxy(1,1'-biphenyl)-3-yl)carbonyl)benzoate
9. Unii-09837k287s
10. Levocloperastine Fendizoate [who-dd]
11. Q27236467
Molecular Weight | 648.2 g/mol |
---|---|
Molecular Formula | C40H38ClNO5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | 647.2438510 g/mol |
Monoisotopic Mass | 647.2438510 g/mol |
Topological Polar Surface Area | 87.1 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 772 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Levocloperastine Fendizoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levocloperastine Fendizoate, including repackagers and relabelers. The FDA regulates Levocloperastine Fendizoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levocloperastine Fendizoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levocloperastine Fendizoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levocloperastine Fendizoate supplier is an individual or a company that provides Levocloperastine Fendizoate active pharmaceutical ingredient (API) or Levocloperastine Fendizoate finished formulations upon request. The Levocloperastine Fendizoate suppliers may include Levocloperastine Fendizoate API manufacturers, exporters, distributors and traders.
click here to find a list of Levocloperastine Fendizoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levocloperastine Fendizoate Drug Master File in Korea (Levocloperastine Fendizoate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levocloperastine Fendizoate. The MFDS reviews the Levocloperastine Fendizoate KDMF as part of the drug registration process and uses the information provided in the Levocloperastine Fendizoate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levocloperastine Fendizoate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levocloperastine Fendizoate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levocloperastine Fendizoate suppliers with KDMF on PharmaCompass.
A Levocloperastine Fendizoate written confirmation (Levocloperastine Fendizoate WC) is an official document issued by a regulatory agency to a Levocloperastine Fendizoate manufacturer, verifying that the manufacturing facility of a Levocloperastine Fendizoate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levocloperastine Fendizoate APIs or Levocloperastine Fendizoate finished pharmaceutical products to another nation, regulatory agencies frequently require a Levocloperastine Fendizoate WC (written confirmation) as part of the regulatory process.
click here to find a list of Levocloperastine Fendizoate suppliers with Written Confirmation (WC) on PharmaCompass.
Levocloperastine Fendizoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levocloperastine Fendizoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levocloperastine Fendizoate GMP manufacturer or Levocloperastine Fendizoate GMP API supplier for your needs.
A Levocloperastine Fendizoate CoA (Certificate of Analysis) is a formal document that attests to Levocloperastine Fendizoate's compliance with Levocloperastine Fendizoate specifications and serves as a tool for batch-level quality control.
Levocloperastine Fendizoate CoA mostly includes findings from lab analyses of a specific batch. For each Levocloperastine Fendizoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levocloperastine Fendizoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levocloperastine Fendizoate EP), Levocloperastine Fendizoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levocloperastine Fendizoate USP).
LOOKING FOR A SUPPLIER?